0000950123-15-006046.txt : 20150514 0000950123-15-006046.hdr.sgml : 20150514 20150514165621 ACCESSION NUMBER: 0000950123-15-006046 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20150331 FILED AS OF DATE: 20150514 DATE AS OF CHANGE: 20150514 EFFECTIVENESS DATE: 20150514 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Polaris Venture Management Co. V, L.L.C. CENTRAL INDEX KEY: 0001439589 IRS NUMBER: 204234752 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16125 FILM NUMBER: 15863739 BUSINESS ADDRESS: STREET 1: 1000 WINTER STREET STREET 2: SUITE 3350 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-290-0770 MAIL ADDRESS: STREET 1: 1000 WINTER STREET STREET 2: SUITE 3350 CITY: WALTHAM STATE: MA ZIP: 02451 13F-HR 1 primary_doc.xml 13F-HR LIVE false true false 0001439589 XXXXXXXX 03-31-2015 03-31-2015 Polaris Venture Management Co. V, L.L.C.
1000 Winter Street Suite 3350 Waltham MA 02451
13F HOLDINGS REPORT 028-16125 N
John Gannon Authorized Signatory 855-787-3500 /s/ John Gannon Waltham MA 05-14-2015 0 7 223829 false
INFORMATION TABLE 2 form13fInfoTable.xml INFORMATION TABLE FOR FORM 13F Bind Therapeutics, Inc. Common Stock 05548N107 11080 2018253 SH SOLE 2018253 0 0 Fate Therapeutics, Inc. Common Stock 31189P102 12094 2473186 SH SOLE 2473186 0 0 Genocea Biosciences, Inc. Common Stock 372427104 24375 2055230 SH SOLE 2055230 0 0 Trevena, Inc. Common Stock 89532E109 24576 3769280 SH SOLE 3769280 0 0 Cerulean Pharma Inc Common Stock 15708Q105 29621 3287529 SH SOLE 3287529 0 0 Ocular Therapeutix, Inc. Common Stock 67576A100 85230 2030009 SH SOLE 2030009 0 0 T2 Biosystems, Inc. Common Stock 89853L104 36853 2374571 SH SOLE 2374571 0 0